BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8813110)

  • 1. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma.
    Lee WC; Balsara B; Liu Z; Jhanwar SC; Testa JR
    Cancer Res; 1996 Oct; 56(19):4297-301. PubMed ID: 8813110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma.
    De Rienzo A; Balsara BR; Apostolou S; Jhanwar SC; Testa JR
    Oncogene; 2001 Sep; 20(43):6245-9. PubMed ID: 11593434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma.
    Bell DW; Jhanwar SC; Testa JR
    Cancer Res; 1997 Sep; 57(18):4057-62. PubMed ID: 9307293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma.
    De Rienzo A; Jhanwar SC; Testa JR
    Genes Chromosomes Cancer; 2000 Jul; 28(3):337-41. PubMed ID: 10862040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma.
    Balsara BR; Bell DW; Sonoda G; De Rienzo A; du Manoir S; Jhanwar SC; Testa JR
    Cancer Res; 1999 Jan; 59(2):450-4. PubMed ID: 9927061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.
    Cheng JQ; Jhanwar SC; Lu YY; Testa JR
    Cancer Res; 1993 Oct; 53(20):4761-3. PubMed ID: 8402655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval.
    Walker GJ; Indsto JO; Sood R; Faruque MU; Hu P; Pollock PM; Duray P; Holland EA; Brown K; Kefford RF; Trent JM; Mann GJ; Hayward NK
    Genes Chromosomes Cancer; 2004 Sep; 41(1):56-64. PubMed ID: 15236317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma.
    Taguchi T; Jhanwar SC; Siegfried JM; Keller SM; Testa JR
    Cancer Res; 1993 Sep; 53(18):4349-55. PubMed ID: 8364929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma.
    Shivapurkar N; Virmani AK; Wistuba II; Milchgrub S; Mackay B; Minna JD; Gazdar AF
    Clin Cancer Res; 1999 Jan; 5(1):17-23. PubMed ID: 9918198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors.
    Mathew S; Murty VV; Bosl GJ; Chaganti RS
    Cancer Res; 1994 Dec; 54(23):6265-9. PubMed ID: 7954476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p).
    Baens M; Wlodarska I; Corveleyn A; Hoornaert I; Hagemeijer A; Marynen P
    Genomics; 1999 Feb; 56(1):40-50. PubMed ID: 10036184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
    Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E
    Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion mapping on the short arm of chromosome 1 in Merkel cell carcinoma.
    Leonard JH; Cook AL; Nancarrow D; Hayward N; Van Gele M; Van Roy N; Speleman F
    Cancer Detect Prev; 2000; 24(6):620-7. PubMed ID: 11198276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1.
    Yokota T; Yoshimoto M; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
    Cancer; 1999 Jan; 85(2):447-52. PubMed ID: 10023714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and refinement of the physical mapping of the gamma- glutamylcysteine ligase regulatory subunit (GLCLR) gene to chromosome 1p22.1 within the critically deleted region of human malignant mesothelioma.
    Rozet JM; Gerber S; Perrault I; Calvas P; Souied E; Châtelin S; Viegas-Péquignot ; Molina-Gomez D; Munnich A; Kaplan J
    Cytogenet Cell Genet; 1998; 82(1-2):91-4. PubMed ID: 9841137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas.
    Balakrishnan A; von Neuhoff N; Rudolph C; Kamphues K; Schraders M; Groenen P; van Krieken JH; Callet-Bauchu E; Schlegelberger B; Steinemann D
    Genes Chromosomes Cancer; 2006 Oct; 45(10):883-92. PubMed ID: 16830336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
    Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T
    Med Pediatr Oncol; 2001 Jan; 36(1):61-6. PubMed ID: 11464908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic and fluorescence in situ hybridization characterization of chromosome 1 rearrangements in head and neck carcinomas delineate a target region for deletions within 1p11-1p13.
    Jin Y; Jin C; Wennerberg J; Mertens F; Höglund M
    Cancer Res; 1998 Dec; 58(24):5859-65. PubMed ID: 9865746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.